INDUCTION CHEMOTHERAPY WITH CISPLATINUM AND 5-FLUOROURACIL FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引:71
|
作者
THYSS, A
SCHNEIDER, M
SANTINI, J
CALDANI, C
VALLICIONI, J
CHAUVEL, P
DEMARD, F
机构
关键词
D O I
10.1038/bjc.1986.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:755 / 760
页数:6
相关论文
共 50 条
  • [41] POLYMER DELIVERY OF CHEMOTHERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    SHIKANI, AH
    EISELE, DW
    DOMB, AJ
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1994, 120 (11) : 1242 - 1247
  • [42] ADJUVANT PREOPERATIVE CHEMOTHERAPY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BRUNTSCH, U
    KAPPAUF, H
    GALLMEIER, WM
    THEISSING, J
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 106 (15) : 451 - 452
  • [43] COMBINATION CHEMOTHERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    COKER, DD
    ELIAS, EG
    CHRETIEN, PB
    GRAY, WC
    COLEMAN, JJ
    ZENTAI, TA
    DIDOLKAR, MS
    MORRIS, DM
    VIRAVATHANA, T
    HEBEL, JR
    [J]. HEAD & NECK SURGERY, 1981, 4 (02): : 111 - 117
  • [44] COMBINATION CHEMOTHERAPY IN ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    ELIAS, EG
    CHRETIEN, PB
    MONNARD, E
    WIERNIK, PH
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 376 - 376
  • [45] Expression of NHEJ genes in head and neck squamous cell carcinoma is associated with tumor response to 5-fluorouracil and cisplatin-based induction chemotherapy
    Pavon, M.
    Parreno, M.
    Leon, X.
    Cespedes, M. V.
    Casanova, I.
    Navas, L. C.
    Mangues, M. A.
    Quer, M.
    Barnadas, A.
    Mangues, R.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 328 - 328
  • [46] Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck:: long-term results of a phase II trial
    Hitt, R
    Paz-Ares, L
    Brandáriz, A
    Castellano, D
    Peña, C
    Millán, JM
    Calvo, F
    de Urbina, DO
    López, E
    Alvarez-Vicent, JJ
    Cortés-Funes, H
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (10) : 1665 - 1673
  • [47] PRIMARY CHEMOTHERAPY OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BRUNTSCH, U
    HILLER, T
    WANDT, H
    WOLFF, L
    THEISSING, J
    GALLMEIER, WM
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (49) : 1889 - 1892
  • [48] SQUAMOUS-CELL CARCINOMA RADIOIMMUNOASSAY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    COOK, DW
    WINEK, T
    BAKER, H
    DEVENEY, CW
    SASAKI, T
    [J]. AMERICAN JOURNAL OF SURGERY, 1989, 157 (05): : 503 - 504
  • [49] ALTERNATING CISPLATINUM AND VAC INEFFECTIVE IN END STAGE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    SIODLAK, MZ
    STELL, PM
    WILSON, JA
    GREEN, JA
    ALLISON, RS
    ADLER, D
    SQUADRELLISARACENO, M
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1990, 104 (08): : 631 - 633
  • [50] FACTORS PREDICTING RESPONSE OF END STAGE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK TO CISPLATINUM
    CAMPBELL, JB
    DORMAN, EB
    HELLIWELL, TR
    MCCORMICK, M
    MILES, J
    MORTON, RP
    RUGMAN, F
    STELL, PM
    STONEY, PJ
    VAUGHAN, ED
    WILSON, JA
    [J]. CLINICAL OTOLARYNGOLOGY, 1987, 12 (03): : 167 - 176